Amazon brings Alexa into healthcare with access to medical information
Category: #health  By Pankaj Singh  Date: 2019-04-09
  • share
  • Twitter
  • Facebook
  • LinkedIn

Amazon brings Alexa into healthcare with access to medical information

Amazon has reportedly been making moves in healthcare sector and after signing an agreement with health providers under the Health Insurance Portability and Accountability Act (HIPAA), users are now free to ask Amazon’s Alexa for their medical records and instantly receive the most recent information their doctors will have.

Apparently, HIPAA was placed to provide data security and privacy for safeguarding medical information and is vital since it governs how sensitive patient data is treated. Health practitioners, medical staff and institutions that have signed under the act are basically allowed to work with Amazon.

As per CNBC’s reports, the health and wellness team of Alexa had been working hard for months to make sure that they are HIPAA-compliant. As of now, six health partners have been chosen for the invite-only program of Amazon, which it expects to develop further in the coming future.

Sources familiar with the matter informed that these new skills have been designed to help customers manage several healthcare requirements at home by simple use of voice, whether it is for accessing hospital post-discharge orders, booking a medical appointment, checking about the status of a prescription delivery and many more.

The global healthcare industry is evidently showing more interest in tech-based companies developing voice-based technology and not only Amazon, but Alphabet is also on the same lines. One of the common explanations is that people as well as seniors with mobility problems are looking for voice tech which is easier to operate as compared to other systems in place today.

Seemingly, Amazon has also teamed up with Berkshire Hathaway and JPMorgan on a joint healthcare venture aimed at improving the healthcare for the companies’ employees. The new venture, named Haven, is controlled and managed by Atul Gawande, who is an American surgeon, public health researcher and writer.



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...